CADTH has implemented a new fee structure that applies to both the Common Drug Review and pan-Canadian Oncology Drug Review programs. The new Guidelines on Application Fees for CADTH Pharmaceutical Reviews replace the separate application fee guidelines which previously existed for each program.
Other important highlights include:
- a reduced fee for the new biosimilar review process
- an annual fee adjustment based on fluctuations in the Consumer Price Index.